nitroaspirin
Small moleculeexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
1
Earliest trial started Mar 1, 2003 (NCT00157508)
Timeline
2000s
- Jan 1, 2003
Earliest Phase 2 Sponsor(trial)
Indications
Approved for
Mechanism of action
- CyclooxygenaseINHIBITOR
Cyclooxygenase inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- 2-acetoxybenzoate-2-(1-nitroxymethyl)phenyl ester
- ncx 4016
- ncx-4016
- ncx-4016
- ncx-4016
- nitric oxide-releasing aspirin
- nitroaspirin
- nitroaspirin
- nitroaspirin
- nitroaspirin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03228017 | Phase 4 | Aug 1, 2017 | New York University |
| NCT01256775 | Phase 2 | Sep 1, 2003 | NicOx, University of Perugia |
| NCT00157508 | Phase 2 | Mar 1, 2003 | Mario Negri Institute |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Mario Negri Institute | Academic/Hospital | 1 | 1 | 1 | 2003 |
| New York University | Academic/Hospital | 1 | 1 | 1 | 2017 |
| NicOx | For profit | 1 | 1 | 1 | 2003 |
| University of Perugia | Academic/Hospital | 1 | 0 | 1 | 2003 |
4 organizations
Page 1 / 1